Goldman Sachs
ARCKW

Goldman Sachs’s Arbor Rapha Capital Bioholdings Corp. I Warrants ARCKW Stock Holding History

Goldman Sachs’s Portfolio ARCKW Stock Details ARCKW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-65,585
Closed -$2.62K – 6479
2022
Q4 		$2.62K Hold
65,585
– – ﹤0.01% 5857
2022
Q3 		$3K Hold
65,585
– – ﹤0.01% 6154
2022
Q2 		$4K Hold
65,585
– – ﹤0.01% 6363
2022
Q1 		$12K Buy
+65,585
New +$24.1K ﹤0.01% 6464

Goldman Sachs's ARCKW Position: Q1 2023 in Review

Goldman Sachs sold out of Arbor Rapha Capital Bioholdings Corp. I Warrants (ARCKW) in Q1 2023, closing a stake of 65,585 shares — an estimated $2.62K sold.

Goldman Sachs first reported a position in ARCKW in Q1 2022 and held it in 4 quarters. The position peaked at $12K in Q1 2022. 1 fund tracked by Wall St. Rank holds ARCKW as of Q1 2023.

  • Goldman Sachs reported no remaining Arbor Rapha Capital Bioholdings Corp. I Warrants position as of Q1 2023 after selling out during the quarter.
  • Goldman Sachs sold 65,585 Arbor Rapha Capital Bioholdings Corp. I Warrants shares in Q1 2023, an estimated $2.62K.
  • Goldman Sachs first reported a position in Arbor Rapha Capital Bioholdings Corp. I Warrants in Q1 2022 and held it in 4 quarters.
  • Goldman Sachs's Arbor Rapha Capital Bioholdings Corp. I Warrants position peaked at $12K in Q1 2022.
  • 1 fund tracked by Wall St. Rank held Arbor Rapha Capital Bioholdings Corp. I Warrants as of Q1 2023.

Based on Goldman Sachs's 13F filing for Q1 2023, filed 11 May 2023.